Allergy immunotherapy tablet: Grazax®for the treatment of grass pollen allergy
about
"The value of pre- and co-seasonal sublingual immunotherapy in pollen-induced allergic rhinoconjunctivitis".Immunotherapy - risk/benefit in food allergy.From IgE to clinical trials of allergic rhinitis.Sublingual immunotherapy provides long-term relief in allergic rhinitis and reduces the risk of asthma: A retrospective, real-world database analysis.New opportunities for allergen immunotherapy using synthetic peptide immuno-regulatory epitopes (SPIREs).Allergen immunotherapy: how to balance the different views from pulmonologists and allergists?
P2860
Allergy immunotherapy tablet: Grazax®for the treatment of grass pollen allergy
description
scientific article published on 01 January 2011
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в січні 2011
@uk
name
Allergy immunotherapy tablet: Grazax®for the treatment of grass pollen allergy
@en
Allergy immunotherapy tablet: Grazax®for the treatment of grass pollen allergy
@nl
type
label
Allergy immunotherapy tablet: Grazax®for the treatment of grass pollen allergy
@en
Allergy immunotherapy tablet: Grazax®for the treatment of grass pollen allergy
@nl
prefLabel
Allergy immunotherapy tablet: Grazax®for the treatment of grass pollen allergy
@en
Allergy immunotherapy tablet: Grazax®for the treatment of grass pollen allergy
@nl
P2860
P356
P1476
Allergy immunotherapy tablet: Grazax® for the treatment of grass pollen allergy
@en
P2093
Moises Calderon
P2860
P356
10.1586/ECI.10.89
P577
2011-01-01T00:00:00Z